Ckg Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-12-2024
- Paid Up Capital ₹ 0.50 M
as on 17-12-2024
- Company Age 19 Year, 24 Days
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 5.46 M
as on 17-12-2024
- Revenue -32.50%
(FY 2018)
- Profit -465.06%
(FY 2018)
- Ebitda -81.05%
(FY 2018)
- Net Worth -30.89%
(FY 2018)
- Total Assets 22.61%
(FY 2018)
About Ckg Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.46 M.
Sanjay Bansal, Devender Parshad, and Krishnamoorthy Chandru serve as directors at the Company.
- CIN/LLPIN
U74899DL2005PTC143069
- Company No.
143069
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 2005
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ckg Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Bansal  | Managing Director | 18-Jul-2007 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devender Parshad | Director | 01-May-2018 | Current |
| Krishnamoorthy Chandru | Director | 29-Nov-2005 | Current |
Financial Performance of Ckg Life Sciences.
Ckg Life Sciences Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 32.5% decrease. The company also saw a substantial fall in profitability, with a 465.06% decrease in profit. The company's net worth observed a substantial decline by a decrease of 30.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ckg Life Sciences?
In 2018, Ckg Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
M Sea Pharmaceuticals Private LimitedActive 9 years 8 monthsKrishnamoorthy Chandru is a mutual person
- Enerbay Lifesciences Private LimitedActive 1 year 8 months
Krishnamoorthy Chandru is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Patiala Creation Date: 14 Jan 2016 | ₹1.00 M | Open |
Punjab National Bank Creation Date: 26 Jun 2008 | ₹0.26 M | Open |
Punjab National Bank Creation Date: 02 Sep 2006 | ₹4.20 M | Open |
How Many Employees Work at Ckg Life Sciences?
Unlock and access historical data on people associated with Ckg Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ckg Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ckg Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
